EP300 is a known target of translocation in ALL [25], and has recently been reported to be recurrently mutated in adult T-ALL [26] and early T-cell precursor T-ALL [27], but not yet in BCP-ALL. The gene discussed is OPN1SW; the disease is acute lymphoblastic leukemia.